An options contract is like a bet on a stock. When you think the stock will go up, you buy a "call" option. When you think the stock will go down, you buy a "put" option. In this story, some people with lots of money are betting that Moderna's stock will go down. They're buying "put" options, which will make them money if the stock does go down. These people are often very smart and they use lots of tools to help them make their bets. Read from source...

"A well-respected critic is a dying breed"

### Export-Import Bank of the United States:
The Export-Import Bank of the United States, also known as Ex-Im Bank, is a government agency that provides financial services to help facilitate and promote U.S. exports. It was established in 1934 and has been reauthorized multiple times since then. The bank offers a range of services, including export credit insurance, working capital guarantees, and direct loans, to support U.S. businesses and their international customers. These services help level the playing field for American companies in the global marketplace and create jobs in the United States.

### Fuel cell vehicles:
Fuel cell vehicles (FCVs) are electric vehicles that utilize hydrogen fuel cells as their primary power source. Unlike traditional internal combustion engine vehicles or battery electric vehicles, FCVs produce electricity through a chemical reaction between hydrogen and oxygen, resulting in water vapor as the only byproduct. This technology offers several advantages, including high efficiency, fast refueling times, and zero tailpipe emissions. However, widespread adoption of FCVs faces challenges such as the limited availability of hydrogen refueling infrastructure and the high cost of producing hydrogen fuel.

### Fuel cell vs. battery electric vehicles:
Fuel cell vehicles (FCVs) and battery electric vehicles (BEVs) are both types of electric vehicles that aim to reduce greenhouse gas emissions and air pollution. While both technologies have their advantages and disadvantages, they differ in terms of energy storage, refueling or recharging methods, driving range, and refueling/recharging times.

FCVs use hydrogen fuel cells to generate electricity, which powers the vehicle's electric motor. They can be refueled quickly with hydrogen gas, allowing for longer driving ranges and shorter refueling times compared to BEVs. However, hydrogen infrastructure is limited, and producing hydrogen fuel can be expensive and energy-intensive.

BEVs store electricity in batteries, which powers the vehicle's electric motor. They can be recharged by plugging into an electric outlet or charging station, but the process takes longer than refueling an FCV with hydrogen. BEVs benefit from a growing network of charging stations, and their batteries can be more easily and cost-effectively charged using renewable energy sources.

Overall, the choice between FCVs and BEVs depends on factors such as individual driving habits, access to refueling/recharging infrastructure, and preferences for refueling/recharging times and vehicle range.

### Hydrogen:
Hydrogen is the most abundant element in the universe and is a key component of water and many organic compounds. It is a

neutral

Title:
Smart Money Is Betting Big In MRNA Options

Category:
Markets

Article Body:
In the world of options trading, the big players have been making some bearish bets on Moderna. This has been noted by Benzinga by studying the options history of Moderna (MRNA). Over the last few months, they detected 11 trades, of which 63% were opened with a bearish sentiment. The total amount spent on these trades is significant, with $365,412 on calls and $259,763 on puts.

The amount of bearish sentiment can be a concern for some investors, as it suggests that these big players are expecting the stock's price to decline. However, it's important to remember that options trading involves a lot of risk, but also offers the potential for high profits. Strategic trades, ongoing education, and being aware of market dynamics can help mitigate these risks.

For those interested in staying on top of options trades for Moderna, Benzinga Pro provides real-time alerts. This can help traders make more informed decisions and potentially increase their chances of success in the options market.

It's also worth considering the company's performance on its own. Moderna's stock has seen a trading volume of 974,610 with a price decline of -0.28% to $72.73. Currently, the RSI suggests that the stock may be approaching oversold. The next earnings report for Moderna is expected in approximately 57 days.

When looking at analyst ratings for Moderna, there have been three recent updates with an average target price of $83.33. JP Morgan maintained a Neutral rating on the stock with a target price of $88. Meanwhile, Deutsche Bank upgraded its rating to Hold with a revised target price of $80, and HSBC also upgraded its rating to Hold with a revised target price of $82.

Overall, while the big players in options trading are making bearish bets on Moderna, it's essential to consider the company's performance, analyst ratings, and risk factors associated with options trading. By staying informed and making strategic decisions, traders can potentially increase their chances of success in the options market.

Since a detailed understanding of a company's financial situation, operating results, management, market, etc. is necessary to evaluate an investment, a comprehensive financial analysis and review are necessary. When evaluating a stock, consider the following:

1. Study the company's financial statements, annual reports, management discussion and analysis (MD&A), and other public records to understand its financial performance and outlook. Look for trends in revenue, earnings, cash flow, and key financial ratios.

2. Research the company's industry, competitors, and market position. Identify factors that may impact the company's growth potential, such as technological advancements, regulatory changes, and shifts in consumer preferences.

3. Evaluate the company's management team and their track record of performance. Consider factors such as their experience, leadership style, and decision-making abilities.

4. Assess the company's strategy and execution. Determine whether the company's strategic initiatives align with its market position and growth objectives. Consider whether the company has the resources and capabilities to execute its strategy effectively.

5. Analyze the company's stock valuation. Compare the company's stock price to its intrinsic value, using metrics such as the price-to-earnings (P/E) ratio, price-to-book (P/B) ratio, and price-to-sales (P/S) ratio. Consider whether the stock is undervalued, fairly valued, or overvalued.

6. Assess the risks associated with investing in the company. Consider factors such as market risk, financial risk, and operational risk. Determine whether the potential returns outweigh the risks.

7. Develop an investment thesis that outlines the reasons for investing in the company and the potential upside and downside scenarios. Regularly monitor the company's performance and update your investment thesis as necessary.

By following these steps, you can develop a comprehensive investment recommendation for a stock, taking into account both the potential upside and downside scenarios.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.

Additionally, I/we have or will receive compensation from a public company or a private third party for providing analyses or other services during the preceding 12 months.

I am short MRNA and believe that the stock is overvalued. The company has no profits and its only revenue is from its Covid vaccine, which is expected to decline. Additionally, the company faces competition from other pharmaceutical companies and is vulnerable to regulatory changes.

I also believe that the stock is highly volatile and that its price is influenced by factors such as news about Covid and other diseases, as